Statins' Ability Reduced By Slow Blood Flow

Scientists at Imperial College London say that slow blood flow in arteries may hinder the protective effect of statins.

The researchers say that slow blood flow tends to reduce statins' ability to trigger production of beneficial antioxidant molecules.

Statins 'Cut Heart Attack Risk by 30pct'
Cholesterol lowering drugs Statins could decrease the risk of heart attacks in healthy people by 30 per cent, according to a new study.

Moreover, the body's own protective mechanisms also tend to fail in the same areas, leaving them vulnerable to damage.

These cholesterol-lowering drugs work by stimulating the production of beneficial antioxidants in the cells of the arteries, by boosting levels of a key enzyme, called heme oxygenase (HO-1).

The researchers examined that the antioxidant potency of statins in different parts of the circulation by measuring the amount of HO-1 in the endothelial cells that line the arteries.

Statins 'don't Cut' Pneumonia Risk in Elderly
Popular cholesterol lowering drugs such as Lipitor (atorvastatin) fail to lower the risk of pneumonia in older adults, finds a new study.

It was found the increase in HO-1 induced by the statin was significantly higher in cells exposed to fast and regular blood flow than in cells where blood flow was sluggish or disrupted.

This shows that statins fail to work well in areas where the body's natural defences are weak.

Red Yeast Rice Pills Could be a Suitable Substitute for Statins
Researchers at the University of Pennsylvania School of Medicine have found that red yeast rice can be an alternative to cholesterol-lowering drugs called statins.

"Arteries don't clog up in a uniform way," the BBC quoted researcher Dr. Justin Mason as saying.

"Bends and branches of blood vessels, where blood flow is disrupted and can be sluggish, are much more prone to fatty plaques building-up and blocking the artery.

"What we have shown is that those regions of the arteries most likely to become diseased are the same regions that may not be benefiting maximally from statin treatment, a double whammy," he added.

The study has been published in the Journal of Biological Chemistry.

Source-ANI
ARU